DEFINITIVE PROXY STATEMENT

Company

Vistagen Therapeutics, Inc.

Filed

August 8, 2016

Period of Report

September 26, 2016

Accession Number

0001415889-16-006705

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →